Enanta Pharmaceuticals, Inc. (ENTA) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Enanta Pharmaceuticals, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -3.12x | -1.89x | -1.75x | -8.78x | -14.51x | -25.24x |
| P/B Ratio | 3.95x | 1.70x | 1.08x | 3.33x | 2.87x | 2.00x |
| P/S Ratio | 3.91x | 3.24x | 2.96x | 12.40x | 11.80x | 7.45x |
| Profitability | ||||||
| Gross Margin | 93.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Margin | -130.7% | -179.9% | -173.2% | -143.7% | -112.9% | -34.0% |
| Net Margin | -125.4% | -171.6% | -169.0% | -141.3% | -81.4% | -29.5% |
| EBITDA Margin | -108.4% | -154.5% | -155.9% | -138.4% | -107.4% | -31.0% |
| Liquidity | ||||||
| Current Ratio | 4.21x | 5.21x | 6.73x | 10.45x | 8.82x | 18.08x |
| Quick Ratio | 4.21x | 5.21x | 6.73x | 10.45x | 8.82x | 18.08x |
| Leverage | ||||||
| Debt/Equity | 3.11x | 1.75x | 1.03x | 0.08x | 0.02x | 0.02x |
YoY = year-over-year change. Source: FMP..